Description
LYNPARZA (Olaparib) is an oral chemotherapy medication prescribed to treat certain types of ovarian and breast cancers. LYNZPARZA is prescribed and managed by an oncologist.
People with cancer have cells that are replicating more often than they should. The replicating cells push into the surrounding tissue, causing damage and taking nutrients intended for other parts of the body.
LYNZPARZA works by preventing the replication of cancer cells, decreasing tumor growth.
Directions
The usual dose is 300 mg by mouth twice daily. LYNPARZA may be taken with or without food.
Ingredients
The active ingredient in LYNPARZA is olaparib.
Fact Table |
Formula |
C24H23FN4O3 |
License |
AU, EU EMA, US FDA |
Bioavailability |
0.5-2 hours |
Legal status |
RX Only |
Chemical Name |
Olaparib |
Elimination half-life |
5-11 hours |
Dosage (Strength) |
150mg (112 tablets) |
Pregnancy |
Consult a doctor |
Brands |
Lynparza |
Protein binding |
82% |
PubChem CID |
23725625 |
MedlinePlus |
a614060 |
ChEBI |
83766 |
ATC code |
L01XK01 |
DrugBank |
DB09074 |
KEGG |
D09730 |
Routes of administration |
By mouth (tablets) |
Interactions
Many different drugs can interact with LYNPARZA. Speak with your oncologist about all of the medications you are taking.
Example of drug interactions include:
- Amprenavir
- Aprepitant
- Atazanavir
- Boceprevir
- Bosentan
- Carbamazepine
- Ciprofloxacin
- Clarithromycin
- Crizotinib
- Darunavir/ritonavir
- Diltiazem
- Efavirenz
- Efavirenz
- Erythromycin
- Etravirine
- Fluconazole
- Fosamprenavir
- Imatinib
- Indiavir
- Itraconazole
- Ketoconazole
- Lopinavir/ritonavir
- Modafinil
- Nafcillin
- Nefazodone
- Nelfinavir
- Phenytoin
- Posaconazole
- Rifampicin
- Ritonavir
- Squinavir
- St. Join's Wort
- Telaprevir
- Telithromycin
- Verapamil
- Voriconazole
Cautions
The tablet and capsule forms are NOT interchangeable. Speak with your doctor if you need to switch from one formulation to another.
Do not drink grapefruit juice or Seville orange juice during treatment with Lynparza because they can increase the levels of the drug.
LYNPARZA is toxic to the developing fetus and should not be used by women who are pregnant. Women should not breastfeed while using this medication.
Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML) is a rare, but fatal side effect of LYNPARZA. Your doctor should monitor for this condition.
Side Effects
Common LYNPARZA side effects can include:
- Anemia
- Arthralgia/myalgia
- Change in laboratory values
- Constipation
- Decreased appetite
- Diarrhea
- Dysgeusia
- Dyspepsia
- Fatigue
- Headache
- Influenza
- Leukopenia
- Nasopharyngitis
- Nausea
- Neutropenia
- Respiratory tract infection
- Stomatitis
- Upper respiratory infection
- Vomiting
References
- Lynparza [package insert]. Wilmington, DE: AstraZeneca; 2018.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13273